Clopidogrel and antiplatelet therapy

References

• Anti-platelet Trialists Collaboration: Secondary prevention of vascular disease by prolonged antiplatelet therapy.Br. Med. J. (1988) 296:320–331.
   PubMed Web of Science ®Google Scholar
• CASTAIGNE A, DUVAL-MOULIN AM, DUTROIT C: Antia-gregants plaquettaires en pathologic coronaire. Rev. Prat. (1989) 39:2228–2233.
   PubMedGoogle Scholar
• LIMET R, DAVID JL, MAGOTTEAUX P: Prevention of aorta coronary bypass graft occlusion. J. Manic. Cardiovasc. Surg. (1987) 94:774–783.
   Google Scholar
• ADAMS D, BOUSSER MG, Antiagregants plaquettaires en pathologic ischemique cerebrale. Rev. Prat. (1989) 39:2234–2240.
   PubMedGoogle Scholar
• HASS WK, EASTON JD, ADAMS HP, ET AL.: A randomized trial comparing ticlopidine hydrochloride with aspirinfor the prevention of stroke in high-risk patients. N Engl. J. Med. (1989) 321:501–507.
   Google Scholar
• GENT M, EASTON JD, HACHINSKI VC, ET AL.: The Cana- dian American Ticlopidine Study (CATS) in throm-boembolic stroke. Lancet (1989) 8649(1):1215–1220.
   Google Scholar
• BOISSEL JP, PEYRIEUX JC, DESTORS JM: Is it possible to reduce the risk of cardiovascular events in subjects suffering from intermittent claudication of the lower limbs? Thromb. Haemost. (1989) 62:681–685.
   Google Scholar
• MAFFRAND JP, DEFREYN G, BERNAT A, DELEBASSEE D,TISSINIER AM: Reviewed pharmacology of ticlopidine. Act. Med. Int. (1988) 77:6–13.
   Google Scholar
• AUBERT D, FERRAND JC, MAFFRAND J: EP 99802 (1983).
   Google Scholar
• BADORC A, FREHEL D: EP 281459 (1988).
   Google Scholar
• SAW P, HERBERT JM, PFLIEGER AM, ET AL.: Importance of hepatic metabolism in the antiaggregating activity of the thienopyridine clopidogrel Biochem. Pharmacol. (1992) 44:527–532.
   Google Scholar
• HERBERT JM, FREHEL D,VALLEE E, BERGER Y, GOUY D, NECCIARI J, DEFREYN G, MAFFRAND JP: Clopidogrel, a novel antiplatelet and antithrombotic agent, Cardiovasc. Drug Rev. (1993) 11:180–198.
   Web of Science ®Google Scholar
• PANAK E, MAFFRAND JP, PICARD-FRAME C, VALLEE E, BLANCHARD J, RONCUCCI R: Ticlopidine: a promise for the prevention and treatment of thrombosis and its complications, Haemostasis (1983) 13:1–54.
   Google Scholar
• DI MINNO G, CERBONE AM, MATTIOLI PL, TURCO S, 'OVINE C, MANCINI M: Functionally thrombasthenic state in normal platelets following the administration of ticlopidine. j Clin. Invest. (1985) 75:328–338.
   PubMed Web of Science ®Google Scholar
• DUNN FW, SORIA J, SORIA C, THOMAIDIS A, LEE H, CAEN JP. In vivo effect of ticlopidine on fibrinogen-platelet cofactor activity and binding of fibrinogen to platelets. Agents Actions (1984) 15:97–103.
   PubMedGoogle Scholar
• GACHET C, STIERLE A, CAZENAVE JP, ET AL.: The thienopyridine PCR 4099 selectively inhibits ADP-in-duced platelet aggregation and fibrinogen binding without modifying the membrane glycoprotein complex in rat and in man. Biochem. PharmacoL (1990) 40:229–238.
   Google Scholar
• MILLS DCB, PLTRI R, HU CJ ET AL.: Clopidogrel inhibits the binding of ADP analogues to the receptor mediating inhibition of platelet adenylate cyclase. Arterioscl. Thromb. (1992) 12:430–436.
   Google Scholar
• SAW P, LAPLACE M-Cl, MAFFRAND JP, HERBERT JM: Bind-ing of [311]-2-Methylthio-ADP to rat platelets - Effect of clopidogrel and tidopidine, J. PharmacoLTber.: Inpress.
   Google Scholar
• MAFFRAND JP, BERNAT A, DELEBASSEE E, DEFREYN G, CAZENAVE JP, GORDON JL: ADP plays a key role in thrombogenesis in rats. Thromb. Haemostas. (1988) 59:225–230.
   PubMed Web of Science ®Google Scholar
• HERBERT JM, BERNAT A, MAFFRAND JP: Aprotinin re- duces clopidogrel-induced prolongation of the bleed-ing time in the rat. Thromb. Res. (1993) 71:433–441.
   PubMed Web of Science ®Google Scholar
• YAO SK, OBER JC, MCNATT J et al.: ADP plays an impor-tant role in mediating platelet aggregation and cyclic flow variations in vivo in stenosed and endothelium-in-jured canine coronary arteries. arc Res (1992) 70:39–48.
   Google Scholar
• HERBERT JM, BERNAT A, MAFFRAND JP: Importance of platelets in experimental venous thrombosis in the rat Blood (1992) 80:2281–2286.
   Google Scholar
• DOL F, GAICH C, BERNAT A, MAURAN G, HERBERT JM: Effect of clopidogrel on thrombin generation in the rat, Thromb. Res. (1992) 65:S160,
   Google Scholar
• CHESEBRO JH, LAM JYT, BADIMON L FUSTER V: Restenosis after arterial angioplasty: a hemorrheologic response to injury. Am]. CardioL (1987) 60:10B–16B.
   Google Scholar
• HERBERT JM, BERNAT A, SAINTE-MARIE M, DOL F, RI- NALDI M: Potentiating effect of clopidogrel and SR 46349, a novel 5HT2 antagonist on streptokinase-in-duced thrombolysis in the rabbit. Thromb. Haemost. (1993) 69:268–271.
   PubMed Web of Science ®Google Scholar
• BERNAT A, DOL F, HERBERT JM, SAINTE-MARIE M, MAF-FRAND JP: Potentiating effects of anticoagulants and antiplatelet agents on streptokinase-induced throm-bolysis in the rabbit. Fibrinolysis (1993) 7:23–30.
   Google Scholar
• YAO SK, McNATT J, ANDERSON HV ET AL.: Concomitantadministration of clopidogrel with tissue type plasmi-nogen activator delays reocclusion after the lysis of thrombi in canine coronary arteries. Circulation (1990) 82:770.
   Google Scholar
• ROSS R: The pathogenesis of atherosclerosis. An update. N. Engl. J. Med. (1986) 314:488–492.
   PubMed Web of Science ®Google Scholar
• HERBERT JM, TISSINIER A, DEFREYN G, MAFFRAND JP: Inhibitory effect of clopidogrel on platelet adhesionand intimal proliferation following arterial injury. Atheroscl. Thromb. (1993) 13:1171–1179.
   PubMedGoogle Scholar
• WHITE cw, cHArrmAN B, KNUDTSON ML, CH1STHOLMRJ and the ticlopidine study group: Antiplatelet agents are effective in reducing the acute ischemic complications of angioplasty but do not prevent restenosis: results from the ticlopidine trial, Coronary Artery Disease (1991) 2:757–767.
   Google Scholar
• PACK Trial group: Prevention of atherosclerotic compli-cations: controlled trial of ketanserin. Br. Med. I (1989) 298:424–430.
   PubMed Web of Science ®Google Scholar
• CHAO BH, JAKUBOWSKI JA, SAVAGE B et a 1.:Agkistrodatspiscivorus platelet aggregation inhibitor: a potent in-hibitor of platelet activation. Proc. Natl. Acad. Sci. USA, (1989) 86:8050–8054.
   Google Scholar
• MUSIAL J, NIEWIAROWSKI S, RUCINSKI B, STEWART GJ, COOK JJ, WILLIAMS JA, EDMUNDS LH: Inhibition of platelet adhesion to surfaces of extracorporeal circuits by disintegrins: RGD-containing peptides from viper venoms. Proc. Soc. Exp. Biol. Med. (1990), 195:168–171.
   PubMedGoogle Scholar
• TOPOL EJ, PLOW EF: Clinical trials of platelet receptors. Thromb. Res. (1993)70:94–98.
   Google Scholar